Table 1 The clinical characteristics of 28 infants included in the study.
From: Ranibizumab after laser photocoagulation failure in retinopathy of prematurity (ROP) treatment
Case/Sex | Int/Ext | GA, weeks | BW, g | Stage/Zone | Plus/Pre-plus | Age at Laser, days | PMA at Laser, weeks | Ranibizumab Injection, eye | Age at Ranibizumab Injection, days | P MA at Ranibizumab Injection, weeks | Time Span between Procedures, days | Retinal Detachment | Visual Function | Follow-up, months |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/F | int | 23 | 480 | APROP/I | plus | 74 | 33 | +/+ | 81 | 34 | 7 | +/+ | − | 31 |
2/F | ext | 23 | 610 | APROP/I | plus | 80 | 34 | +/+ | 86 | 35 | 6 | −/− | + | 24 |
3/M | int | 23 | 665 | APROP/I | plus | 70 | 33 | +/+ | 77 | 34 | 7 | −/− | + | 38 |
4/M | int | 24 | 540 | APROP/I | plus | 87 | 36 | +/+ | 108 | 39 | 21 | −/− | + | 15 |
5/F | int | 24 | 620 | APROP/I | plus | 87 | 36 | −/+ | 135 | 43 | 48 | −/ | − | 11 |
6/M | int | 24 | 640 | 3/I | plus | 69/88 | 33/36 | +/+ | 97 | 37 | 28 | +/+ | − | 57 |
7/M | int | 24 | 685 | 3/cII | plus | 80 | 35 | +/+ | 104 | 38 | 24 | +/− | + | 66 |
8/M | int | 24 | 750 | 3/cII | plus | 65 | 33 | +/+ | 86 | 36 | 21 | −/− | + | 36 |
9/M | int | 24 | 760 | 3/I | pre-plus | 64 | 33 | +/+ | 94 | 37 | 30 | −/− | + | 25 |
10/M | int | 24 | 780 | 1/I | pre-plus | 64 | 33 | +/+ | 73 | 34 | 9 | −/− | + | 13 |
11/M | int | 24 | 887 | 3/II | plus | 59 | 32 | +/+ | 83 | 35 | 24 | −/− | + | 39 |
12/F | int | 25 | 550 | 3/I | plus | 65 | 34 | +/+ | 91 | 38 | 26 | −/+ | + | 65 |
13/M | int | 25 | 585 | 3/II | plus | 72 | 35 | +/+ | 94 | 38 | 22 | −/− | + | 24 |
14/M | int | 25 | 767 | 1/I | plus | 75 | 35 | +/+ | 82 | 36 | 7 | +/− | + | 14 |
15/M | int | 25 | 770 | APROP/I | pre-plus | 64 | 34 | −/+ | 92 | 38 | 28 | /+ | − | 53 |
16/F | int | 25 | 785 | 3/cII | plus | 50 | 32 | +/+ | 57 | 33 | 7 | −/− | + | 32 |
17/M | int | 25 | 810 | 1/I | plus | 71 | 35 | +/+ | 104 | 39 | 33 | −/− | + | 29 |
18/F | int | 25 | 825 | 1/I | plus | 58 | 33 | +/+ | 72 | 35 | 14 | −/− | + | 21 |
19/M | int | 25 | 830 | 2/cII | plus | 57 | 33 | +/+ | 78 | 36 | 21 | −/− | + | 25 |
20/F | ext | 25 | 850 | APROP/I | plus | 67 | 34 | +/+ | 76 | 35 | 9 | +/− | + | 55 |
21/M | ext | 25 | 870 | 3/II | plus | 71 | 35 | +/+ | 83 | 36 | 12 | −/− | + | 36 |
22/M | int | 26 | 520 | 3/I | pre-plus | 73 | 36 | +/+ | 95 | 39 | 22 | −/− | + | 13 |
23/M | int | 26 | 620 | 3/I | plus | 66 | 35 | +/− | 93 | 39 | 27 | −/ | + | 39 |
24/F | int | 26 | 750 | 3/I | plus | 57 | 34 | +/+ | 71 | 36 | 14 | −/+ | + | 38 |
25/M | int | 26 | 1105 | 3/II | plus | 66 | 35 | +/+ | 87 | 38 | 21 | −/− | + | 16 |
26/M | int | 27 | 1225 | 2/I | pre-plus | 46 | 33 | +/+ | 74 | 37 | 28 | −/− | + | 16 |
27/M | ext | 28 | 1400 | 3/I | plus | 52 | 35 | +/+ | 66 | 37 | 14 | +/+ | − | 65 |
28/M | ext | 30 | 1450 | 3/II | plus | 61 | 38 | +/+ | 63 | 39 | 2 | −/− | + | 63 |
